Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.

Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H, Pedersen BK.

Diabetologia. 2007 Feb;50(2):431-8. Epub 2006 Dec 7.

PMID:
17151862
2.

Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance.

Fujinami A, Ohta K, Obayashi H, Fukui M, Hasegawa G, Nakamura N, Kozai H, Imai S, Ohta M.

Clin Biochem. 2008 Jul;41(10-11):812-7. doi: 10.1016/j.clinbiochem.2008.03.003. Epub 2008 Mar 19.

PMID:
18402781
3.

Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus.

Suwa M, Kishimoto H, Nofuji Y, Nakano H, Sasaki H, Radak Z, Kumagai S.

Metabolism. 2006 Jul;55(7):852-7.

PMID:
16784955
4.

Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice.

Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD, Wiegand SJ, Wong V.

Diabetes. 1999 Mar;48(3):588-94.

PMID:
10078561
5.

Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals.

Pedersen BK, Pedersen M, Krabbe KS, Bruunsgaard H, Matthews VB, Febbraio MA.

Exp Physiol. 2009 Dec;94(12):1153-60. doi: 10.1113/expphysiol.2009.048561. Epub 2009 Sep 11. Review.

6.

Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.

Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.

Diabetes Obes Metab. 2007 Nov;9(6):879-88.

PMID:
17924870
7.

Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function.

Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, Guthoff M, Silbernagel G, Stefan N, Häring HU, Fritsche A.

PLoS One. 2008;3(12):e3962. doi: 10.1371/journal.pone.0003962. Epub 2008 Dec 17.

8.

BDNF Val66Met polymorphism is associated with unstable angina.

Jiang H, Wang R, Liu Y, Zhang Y, Chen ZY.

Clin Chim Acta. 2009 Feb;400(1-2):3-7. doi: 10.1016/j.cca.2008.10.017. Epub 2008 Oct 30.

PMID:
19013140
9.

Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

J Clin Lab Anal. 2007;21(2):85-90.

PMID:
17385686
10.

Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.

Dahlgren A, Zethelius B, Jensevik K, Syvänen AC, Berne C; ULSAM Cohort..

Diabetologia. 2007 Sep;50(9):1852-7. Epub 2007 Jul 6.

PMID:
17618413
11.

Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism.

Hanyu O, Yamatani K, Ikarashi T, Soda S, Maruyama S, Kamimura T, Kaneko S, Hirayama S, Suzuki K, Nakagawa O, Nawa H, Aizawa Y.

Diabetes Obes Metab. 2003 Jan;5(1):27-37.

PMID:
12542722
12.

Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.

Nakagawa T, Ono-Kishino M, Sugaru E, Yamanaka M, Taiji M, Noguchi H.

Diabetes Metab Res Rev. 2002 May-Jun;18(3):185-91. Review.

PMID:
12112936
13.

Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.

Yamanaka M, Itakura Y, Ono-Kishino M, Tsuchida A, Nakagawa T, Taiji M.

J Biosci Bioeng. 2008 Apr;105(4):395-402. doi: 10.1263/jbb.105.395.

PMID:
18499057
14.

Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases.

Horiki M, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M, Shimamoto K, Ogihara T.

Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S63-7.

PMID:
15563983
15.

Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.

Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E758-64. doi: 10.1152/ajpendo.90737.2008. Epub 2009 Feb 3.

16.
17.

Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort.

Hagström E, Hellman P, Lundgren E, Lind L, Arnlöv J.

Diabetologia. 2007 Feb;50(2):317-24. Epub 2006 Dec 20.

PMID:
17180664
18.

Brain-derived neurotrophic factor ameliorates hepatic insulin resistance in Zucker fatty rats.

Kuroda A, Yamasaki Y, Matsuhisa M, Kubota M, Nakahara I, Nakatani Y, Hoshi A, Gorogawa S, Umayahara Y, Itakura Y, Nakagawa T, Taiji M, Kajimoto Y, Hori M.

Metabolism. 2003 Feb;52(2):203-8.

PMID:
12601633
19.

Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice.

Sha H, Xu J, Tang J, Ding J, Gong J, Ge X, Kong D, Gao X.

Physiol Genomics. 2007 Oct 22;31(2):252-63. Epub 2007 Jul 24.

20.

Chronic ethanol ingestion, type 2 diabetes mellitus, and brain-derived neurotrophic factor (BDNF) in rats.

Jung KI, Ju A, Lee HM, Lee SS, Song CH, Won WY, Jeong JS, Hong OK, Kim JH, Kim DJ.

Neurosci Lett. 2011 Jan 7;487(2):149-52. doi: 10.1016/j.neulet.2010.10.011. Epub 2010 Oct 12.

PMID:
20946939

Supplemental Content

Support Center